Compare GANX & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GANX | SUNS |
|---|---|---|
| Founded | 2017 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.2M | 128.7M |
| IPO Year | 2021 | N/A |
| Metric | GANX | SUNS |
|---|---|---|
| Price | $3.98 | $10.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $8.00 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 1.2M | 89.8K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 11.67% |
| EPS Growth | N/A | ★ 1112.46 |
| EPS | N/A | ★ 1.09 |
| Revenue | N/A | ★ $19,384,703.00 |
| Revenue This Year | N/A | $174.58 |
| Revenue Next Year | N/A | $60.45 |
| P/E Ratio | ★ N/A | $9.42 |
| Revenue Growth | N/A | ★ 2540.16 |
| 52 Week Low | $1.41 | $7.80 |
| 52 Week High | $4.34 | $14.87 |
| Indicator | GANX | SUNS |
|---|---|---|
| Relative Strength Index (RSI) | 69.52 | 56.34 |
| Support Level | $3.94 | $10.04 |
| Resistance Level | $4.34 | $10.38 |
| Average True Range (ATR) | 0.38 | 0.34 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 77.78 | 75.48 |
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.